NCT01120873

The Effect of Metamin 3D on the Lipid and Glucose in Subjects With Metabolic Syndrome

Phase 3 Study of 3D in Metabolic Syndrome

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 110 (actual)
• Sponsor: Taichung Veterans General Hospital · Academic / Other
• Sex: All
• Age: 30 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the effect of Metamin 3D on improvement of glucose and lipid on Taiwanese subjects with metabolic syndrome.

Detailed description

The Metamin 3D consists of mixed extractives of nature plants, including soy bean protein, bitter melon, red yeast rice, green algae and trisodium glycyrrhizinate. the improvement of lipid and glucose was reported respectively previously. We design a prospective, double-blinded and placebo-controlled study to evaluate the improvement on metabolic syndrome.

Conditions

• Metabolic Syndrome

Interventions

Type	Name	Description
DRUG	Metamin 3D	Metamin 3D is composed by red yeast rice, bitter gourd, chlorella, soy peptide and licorice extract is a commercial product designed by Uni-President enterprises corp in Taiwan

Timeline

• Start date: 2007-03-01
• Primary completion: 2009-06-01
• Completion: 2009-06-01
• First posted: 2010-05-11
• Last updated: 2010-05-11

Locations

1 site across 1 country: Taiwan